from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1978/-

LFCtreatmentdescriptionclass of inhibitor

0.614

Amikacinug/mL Amikacintranslation

1.615

Cap5-10ug/mL Capreomycintranslation

1.277

Rox10-50 ug/mL Roxithromycintranslation

-0.289

SM2-5 ug/mL Streptomycintranslation

-0.441

Tet5-10 ug/mL Tetracyclinetranslation

0.792

Rif0.2-5ug/mL Rifampicintranscription

-0.485

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.036

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.226

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.723

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.812

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.334

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.146

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.289

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.533

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.291

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.139

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.351

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.219

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.221

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.770

KCN5-20 ug/mL Potassium cyaniderespiration

-0.329

NaN30.2-2 mM Sodium aziderespiration

1.758

Nigericin50 uM Nigericinrespiration

0.443

TRC10-150 ug/mL Triclosanrespiration

1.892

TRZ10-25 ug/mL Thioridazinerespiration

2.236

Valinomycin0.5-10 uM Valinomycinrespiration

-1.417

ZnSO42 mM ZnSO4respiration

-0.175

menadione6-10 ug/mL Menadionerespiration

-0.481

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.083

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.492

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.444

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.137

NRP_1Non-replicating persistence stage 1dosRassociated

-0.409

Amp0.2mg/mL AmpicillincellWall

0.195

Cephalexin20-100 ug/mL CephalexincellWall

0.023

Cerulenin0.32-5 ug/mL CerulenincellWall

0.137

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.102

EMB10-20 ug/mL EthambutolcellWall

-0.010

Eta12-40 ug/mL EthionamidecellWall

-0.567

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.029

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.888

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.545

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.203

BZA0.12 mg/mL BenzamidearomaticAmides

0.310

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.376

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.198

H2O24 mM hydrogen peroxideDNAdamaging

-0.223

Levo10 ug/mL LevofloxacinDNAdamaging

0.199

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.894

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.187

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.648

UVUV-irradiationDNAdamaging

-0.599

ARP41-4 ug/mL Antitubercular compound ARP4?

0.296

Antimycin12.5-50 ug/mL Antimycin A?

0.183

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.077

PA_110-50 ug/mL Antitubercular compound PA-1?

0.530

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.974

PA8240.2-2 ug/mL PA-824?

-0.371

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.912

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.028

Verapamil50 uM Verapamil?

0.386

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.687

methoxatin10-20 ug/mL Methoxatin?